Review Articles

Persistence of myelofibrosis treated with ruxolitinib: biology and clinical implications

Department of Hematology and Bone Marrow Transplantation, Royal Adelaide Hospital, Adelaide; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide; Precision Medicine Theme, South Australian Health and Medical Research Institute, and Adelaide Medical School, University of Adelaide
The Walter and Eliza Hall Institute of Medical Research and Department of Medical Biology, University of Melbourne, Parkville
Centre for Cancer Biology, University of South Australia and SA Pathology
Precision Medicine Theme, South Australian Health and Medical Research Institute, and Adelaide Medical School, University of Adelaide
Haematologica Early view Jan 21, 2021 https://doi.org/10.3324/haematol.2020.262691